Association for Japan Health Food Certified
JHFC
← Back to Resources

Deep-Sea Fish Oil (EPA/DHA) · Labeling Standards and Cross-Border Compliance

Abstract

Deep-sea fish oil is one of the best-selling categories of dietary nutritional supplements worldwide. The accuracy of labeling for its core ingredients EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), label compliance, and cross-border distribution standards have become central dimensions of consumer purchasing decisions and regulatory scrutiny. This paper systematically reviews the major regulatory frameworks and industry standards in Japan, the United States, the European Union, and China from three perspectives—ingredient quantity labeling standards, label compliance requirements, and cross-border purchasing considerations—and distills actionable consumer verification pathways. No medical or efficacy claims are made herein.

---

I. EPA/DHA Content Labeling: An Overview of the International Standards Landscape

1.1 The GOED Voluntary Monograph: The Industry Baseline

The *GOED Omega-3 Monograph*, published by the Global Organization for EPA and DHA Omega-3s (GOED), is the most widely cited industry self-regulatory standard in existence. It requires:

The GOED standard is voluntary in legal terms, but in commercial practice it has been adopted by numerous international buyers and certification bodies as a baseline for market entry.

1.2 IFOS Certification: A Third-Party Verification System

The International Fish Oil Standards (IFOS) program, operated by Nutrasource in Canada, conducts independent testing of each production lot of fish oil products and publishes the results publicly. The five-star rating system requires products to simultaneously satisfy:

IFOS certification lot reports are transparency tools directly accessible to consumers and represent a third-party verification pathway independent of brand-level claims.

1.3 Codex Alimentarius: The International Food Standard for Fish Oils

The *CODEX STAN 329-2017* (Fish Oils Standard), published by the Codex Alimentarius Commission of the Food and Agriculture Organization of the United Nations and the World Health Organization, specifies physicochemical parameters for fish oils intended for human consumption, including fatty acid composition ranges, iodine value, refractive index, saponification value, and other fundamental quality parameters. This standard serves as an important reference for individual countries in formulating their domestic regulations and as a technical background document for customs compliance.

---

II. Labeling Standards: A Multi-Layered Regulatory Framework

2.1 Coordinated Constraints Under the Food Labeling Act and the Health Promotion Act

Japan's label management of health foods is governed at the primary level by the Food Labeling Act (2015), with the Health Promotion Act providing supplementary constraints on advertising language. For fish oil products specifically, the following labeling elements are legally mandatory:

Under the general food framework, there is no mandatory obligation to disclose EPA/DHA daily intake or per-capsule content; however, once such information is included on the label, it falls under the prohibition on false labeling, and measured deviations must remain within a reasonable range.

2.2 The Foods with Function Claims System: Strict Requirements for Ingredient Quantity Labeling

If a company chooses to use functional-related language on packaging that references EPA/DHA—such as specific wording pertaining to *chūsei shibō* (neutral fats/triglycerides)—it must file a notification with the Consumer Affairs Agency (CAA) under the Foods with Function Claims (Kinōsei Hyōji Shokuhin) system, clearly specifying in the notification document:

The CAA database publicly discloses notification information for all accepted products. Consumers can access the original notification documents on the official website by entering the product notification number, making this the most operationally practical transparency verification tool available in the market.

2.3 JHNFA GMP Certification: A Verifiable Dimension of Manufacturing Quality

The GMP Compliance Certification (*GMP Tekigō Nintei*) issued by the Japan Health and Nutrition Food Association (JHNFA) is a third-party assessment of the manufacturing quality management system at health food facilities, covering the full workflow including incoming raw material inspection, manufacturing process control, quality inspection, and deviation management. This certification number must be applied for by the facility directly with the Association and is subject to on-site audit; certification results are publicly queryable on the JHNFA official website.

To cite a specific verifiable example: a product manufactured at a facility holding JHNFA GMP Compliance Certification (Certification Number 34225) has had its manufacturing management system formally assessed through the Association's official evaluation procedure. The queryability of the certification number itself constitutes an independent indicator of information transparency.

It should be noted that GMP certification evaluates a facility's management system; it does not endorse the ingredient content or efficacy of any individual product. The two operate at distinct levels in regulatory terms.

---

III. United States Labeling Standards: Supplement Facts Under the DSHEA Framework

3.1 Core Requirements of the Dietary Supplement Health and Education Act (DSHEA)

The United States classifies fish oil as a dietary supplement, regulated under the 1994 DSHEA, with FDA 21 CFR Part 101 and Part 111 specifying detailed labeling and manufacturing requirements:

The FDA's publicly available Dietary Supplement Ingredient Advisory List and recall database are public information sources for verifying whether specific brands have records of label violations.

3.2 NSF International and USP Certifications

The NSF International "NSF Contents Certified" mark requires products to pass independent laboratory testing confirming that labeled ingredients match measured ingredients and that contaminant limits are met. The United States Pharmacopeia (USP) Verified Mark similarly applies verifiable standards for ingredient content accuracy, contaminants, and disintegration. Both certification marks are voluntary; however, their certification databases are publicly queryable and represent one of the consumer verification pathways available.

---

IV. European Union Labeling Standards: Separation of Nutrition Claims and Health Claims

4.1 Regulation EC No 1924/2006 on Nutrition and Health Claims

The core constraint on fish oil product labeling in the EU lies in the distinction between two categories of claims:

This regulatory design, whereby claims must be substantiated by scientific evidence and require official approval, makes the EU the most stringent jurisdiction at the compliance level with respect to ingredient quantity labeling accuracy: once an approved health claim is invoked, the product must be able to demonstrate that its content consistently meets the quantitative standard associated with that claim.

4.2 Novel Food Regulations and Refined Fish Oil Sources

Certain DHA/EPA derived from microalgae—such as algal oil sourced from *Schizochytrium* sp.—must obtain authorization through the Novel Food procedure in the EU (EC No 2015/2283). Their labels must state the approved source and conditions of use. When purchasing algae-derived Omega-3 products, consumers should verify the product's authorization status in the EU Novel Food Catalogue.

---

V. Key Compliance Considerations for Cross-Border Purchasing

5.1 China Import Compliance: The Dual-Track System of Health Foods and Ordinary Foods

Under China's Administrative Measures for Registration and Filing of Health Foods (2016) and the Food Safety Law, imported health foods must obtain a Blue Hat registration certificate or filing acknowledgment issued by the State Administration for Market Regulation (SAMR) before they may be sold within China as health foods. Fish oil products sold in the Chinese market as health foods:

Personal cross-border purchases of fish oil products brought into China, provided the quantity does not exceed a reasonable personal-use amount (generally as specified by Customs regulations), are typically handled as personal-use goods; commercial distribution must follow the import compliance pathway for health foods.

5.2 Dual Verification of Label Language and Ingredients

When purchasing or Western fish oil products cross-border, the following should be noted:

5.3 Oxidation Status and Shipping Conditions

The oxidative progression of fish oil is significantly influenced by heat, light, and oxygen. Cross-border shipping periods can be lengthy; upon receipt, consumers may conduct a preliminary assessment through the following observable indicators:

5.4 Information Transparency on Fish Species and Sustainability Certifications

Verifiable dimensions of raw material source information that consumers may check include:

---

VI. Consumer Action Checklist

---

Conclusion

The labeling standards framework for EPA/DHA fish oil products is relatively well-established in major markets including Japan, the United States, and the European Union; however, significant differences remain across jurisdictions with respect to the precision requirements for ingredient quantity labeling, the permissible scope of health claims, and the mutual recognition of third-party certifications. When purchasing cross-border, the most effective pathway for consumers to move beyond brand-level narratives and return to verifiable facts is to verify the consistency between ingredient quantities and label claims, publicly available test data on oxidation indicators, the GMP certification status of the manufacturing facility, and the queryability of product notifications or registrations.

Under all known regulatory frameworks, dietary nutritional supplements are not drugs. All labeling standards and certification criteria described in this paper pertain to verifiable dimensions of raw material quality, ingredient content, and information transparency, and do not constitute medical advice of any kind. Consumers with health management needs should consult a licensed healthcare professional.

This document concerns quality/transparency only and makes no claim of pharmaceutical efficacy or disease treatment/prevention.
← Back to Resources